US Patent Issued to I2O THERAPEUTICS on June 24 for "Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,029, issued on June 24, was assigned to I2O THERAPEUTICS INC. (Cambridge, Mass.).

"Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof" was invented by Tyler Brown (Cambridge, Mass.) and Kelly Ibsen (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds having the structure of Formula I, wherein the compounds comprise a therapeutic agent having the configuration of [diacid]-[linker]-[an amylin analog], in which the amylin analog has the amino acid sequence of SEQ ID NO: 20, with a proviso that the amino acid sequence comprises one or more of the following amino acid substitutions...